Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of commercial applications of antiviral drug treatments that utilize a class of fusion inhibitors.The company develops novel anti human immunodeficiency virus therapeutics.
You’re viewing a free company profile from the PitchBook Platform. To explore Trimeris’s full profile, request a free trial.
This information is reserved for PitchBook Platform users. To explore Trimeris‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.